Gene · 1066
Papers3,256
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,256
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| General anesthesia with remimazolam for emergency cesarean section in a patient with acute infective endocarditis: a case report. | JA Clin Rep | 2023 | 37612528 | PubTator, text mining | PubMed |
| Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach. | Sci Rep | 2023 | 37607964 | PubTator, text mining | PubMed |
| Remdesivir: A Review in COVID-19. | Drugs | 2023 | 37589788 | PubTator, text mining | PubMed |
| Endogenous and Therapeutic 25-Hydroxycholesterols May Worsen Early SARS-CoV-2 Pathogenesis in Mice. | Am J Respir Cell Mol Biol | 2023 | 37578898 | PubTator, text mining | PubMed |
| Discovering metabolic vulnerability using spatially resolved metabolomics for antitumor small molecule-drug conjugates development as a precise cancer therapy strategy. | J Pharm Anal | 2023 | 37577390 | PubTator, text mining | PubMed |
| IL-33 Downregulates Hepatic Carboxylesterase 1 in Acute Liver Injury via Macrophage-derived Exosomal miR-27b-3p. | J Clin Transl Hepatol | 2023 | 37577217 | PubTator, text mining | PubMed |
| Cellular metabolism hijacked by viruses for immunoevasion: potential antiviral targets. | Front Immunol | 2023 | 37559723 | PubTator, text mining | PubMed |
| CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. | Clin Transl Sci | 2023 | 37551775 | PubTator, text mining | PubMed |
The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 2: study protocol for a hybrid type 2 effectiveness-implementation cluster-randomized trial using train-the-trainer. | Trials | 2023 | 37550730 | PubTator, text mining | PubMed |
| Cannabidiol's impact on drug-metabolization. | Eur J Intern Med | 2023 | 37541924 | PubTator, text mining | PubMed |
| The development of blood protein profiles in extremely preterm infants follows a stereotypic evolution pattern. | Commun Med (Lond) | 2023 | 37532738 | PubTator, text mining | PubMed |
| How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy? | Int J Mol Sci | 2023 | 37511612 | PubTator, text mining | PubMed |
| The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away. | Cancers (Basel) | 2023 | 37509198 | PubTator, text mining | PubMed |
Comparative Metagenomic and Metatranscriptomic Analyses Reveal the Response of Black Soldier Fly (Hermetia illucens) Larvae Intestinal Microbes and Reduction Mechanisms to High Concentrations of Tetracycline. | Toxics | 2023 | 37505576 | PubTator, text mining | PubMed |
| Interactions of the Kv1.1 Channel with Peptide Pore Blockers: A Fluorescent Analysis on Mammalian Cells. | Membranes (Basel) | 2023 | 37505011 | PubTator, text mining | PubMed |
| Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. | Sci Transl Med | 2023 | 37494474 | PubTator, text mining | PubMed |
| An E-cadherin-actin clutch translates the mechanical force of cortical flow for cell-cell contact to inhibit epithelial cell locomotion. | Dev Cell | 2023 | 37480844 | PubTator, text mining | PubMed |
| Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX. | Sci Rep | 2023 | 37479788 | PubTator, text mining | PubMed |
| Characteristics of alpha-fetoprotein-positive gastric cancer revealed by analysis of cancer databases and transcriptome sequencing data. | Transl Oncol | 2023 | 37478671 | PubTator, text mining | PubMed |
| Epigenetic regulation of bone remodeling and its role in the pathogenesis of primary osteoporosis. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37465189 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1066/papers?page=18